Panitumumab (Vectibix®) as 1st-line combination therapy for the treatment of WT KRAS colorectal cancer – 1st Update 2011
Ludwig Boltzmann Institute for Health Technology Assessment
Record ID 32012000259
English
Authors' recommendations:
These findings highlight the fact that despite the availability of several different treatment options for mCRC further research is required to find the optimal sequence of the available agents, the ideal combination with chemotherapy and the optimal duration of treatment.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://eprints.hta.lbg.ac.at/936
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Austria
MeSH Terms
- Antibodies, Monoclonal
- Antineoplastic Combined Chemotherapy Protocols
- Colorectal Neoplasms
Contact
Organisation Name:
Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address:
Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name:
tarquin.mittermayr@aihta.at
Contact Email:
office@aihta.at
Copyright:
Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.